Page last updated: 2024-10-26

racemetirosine and Cardiac Cancer

racemetirosine has been researched along with Cardiac Cancer in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Research Excerpts

ExcerptRelevanceReference
"Biochemical studies confirmed its recurrence."1.29An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside. ( Acheson, LS; Anton, AH; Lina, AA; Sherman, BW, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anton, AH1
Sherman, BW1
Lina, AA1
Acheson, LS1

Other Studies

1 other study available for racemetirosine and Cardiac Cancer

ArticleYear
An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
    International journal of clinical pharmacology, therapy, and toxicology, 1993, Volume: 31, Issue:2

    Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Catecholamines; Drug Resistance; Echocardiography; Fe

1993